PillDrill unveils a $199 smart medication tracking system
The solution is easy to use, and can adapt to any medication routine; also, it works whether a person manages their own or a loved one's pill regimen.
Medisafe, Nestlé Health Science to help patients prepare for surgery
Personalized adherence platform will be used to help patients take Nestlé Health Science's IMPACT ADVANCED RECOVERY Specialized Nutrition Drink.
RxREVU raises $3M for its medication optimization solution
The company has developed a next generation prescription decision support at the point of care to help large health systems reduce costs and improve outcomes.
Medisafe Providers enables doctors to track their patients’ medication adherence
The new, adherence feature is visible alongside patient biometric measurements such as blood pressure, glucose, weight, and so on.
SureAdhere brings its Video Directly Observed Therapy to iOS, Android mobiles and tablets
Backed by peer reviewed clinical research, the solution provides a cost-effective method to ensure patient compliance for tuberculosis (TB) treatment.
New mobile service offers lowest prices on generic prescription drugs
Called Blink Health, it says that half of the drugs in its database are priced at $10 or less, creating savings of up to 99 percent on prescriptions.
HealthBeacon gets $1.1M for its medication adherence tech
The company has developed a mobile-connected sharps container that people who take injectable medications can use to discard their needles.
mscripts, McKesson to help patients save on and adhere to their medications
In March of this year, the two companies will launch a solution that connects mscripts' network of 6,000+ pharmacies with MPRS' savings and adherence programs.
GSC & MEMOTEXT pilot: Text messages help with medication adherence
A personalized digital health intervention can improve adherence for hypertension and high cholesterol patients, providing value to all parties involved.
Pear Therapeutics gets $20M for its prescription digital therapies
The company will use the money to build and launch a portfolio of eFormulations, including reSET and reSET-O, for treating substance use disorder.








